Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells

被引:49
作者
Hussain, Althaf I. [1 ]
Cordeiro, Melissa [1 ]
Sevilla, Elizabeth [1 ]
Liu, Jonathan [1 ]
机构
[1] MedImmune LLC, Cell Culture Proc Dev, Santa Clara, CA 95054 USA
关键词
Live attenuated influenza vaccine (LAIV); MDCK; EFFICACY; SAFETY; SYSTEM; ADULTS; VERO;
D O I
10.1016/j.vaccine.2010.03.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Currently MedImmune manufactures cold-adapted (ca) live, attenuated influenza vaccine (LAW) from specific-pathogen free (SPF) chicken eggs. Difficulties in production scale-up and potential exposure of chicken flocks to avian influenza viruses especially in the event of a pandemic influenza outbreak have prompted evaluation and development of alternative non-egg based influenza vaccine manufacturing technologies. As part of MedImmune's effort to develop the live attenuated influenza vaccine (LAIV) using cell culture production technologies we have investigated the use of high yielding, cloned MDCK cells as a substrate for vaccine production by assessing host range and virus replication of influenza virus produced from both SPF egg and MDCK cell production technologies. In addition to cloned MDCK cells the indicator cell lines used to evaluate the impact of producing LAIV in cells on host range and replication included two human cell lines: human lung carcinoma (A549) cells and human muco-epidermoid bronchiolar carcinoma (NCI H292) cells. The influenza viruses used to infect the indicators cell lines represented both the egg and cell culture manufacturing processes and included virus strains that composed the 2006-2007 influenza seasonal trivalent vaccine (A/New Caledonia/20/99 (H1N1), A/Wisconsin/67/05 (H3N2) and B/Malaysia/2506/04). Results from this study demonstrate remarkable similarity between influenza viruses representing the current commercial egg produced and developmental MDCK cell produced vaccine production platforms. MedImmune's high yielding cloned MDCK cells used for the cell culture based vaccine production were highly permissive to both egg and cell produced ca attenuated influenza viruses. Both the A549 and NCI H292 cells regardless of production system were less permissive to influenza A and B viruses than the MDCK cells. Irrespective of the indicator cell line used the replication properties were similar between egg and the cell produced influenza viruses. Based on these study results we conclude that the MDCK cell produced and egg produced vaccine strains are highly comparable. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3848 / 3855
页数:8
相关论文
共 28 条
[1]  
Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x
[2]   Cell-based influenza vaccines: Progress to date [J].
Audsley, Jennifer M. ;
Tannock, Gregory A. .
DRUGS, 2008, 68 (11) :1483-1491
[3]   The growth of attenuated influenza vaccine donor strains in continuous cell lines [J].
Audsley, JM ;
Tannock, GA .
JOURNAL OF VIROLOGICAL METHODS, 2005, 123 (02) :187-193
[4]   Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years [J].
Belshe, RB ;
Nichol, KL ;
Black, SB ;
Shinefield, H ;
Cordova, J ;
Walker, R ;
Hessel, C ;
Cho, I ;
Mendelman, PM .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) :920-927
[5]   Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children [J].
Belshe, RB ;
Gruber, WC .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2001, 356 (1416) :1947-1951
[6]  
Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643
[7]   Live attenuated versus inactivated influenza vaccine in infants and young children [J].
Belshe, Robert B. ;
Edwards, Kathryn M. ;
Vesikari, Timo ;
Black, Steven V. ;
Walker, Robert E. ;
Hultquist, Micki ;
Kemble, George ;
Connor, Edward M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07) :685-696
[8]   Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release [J].
Brydon, EWA ;
Smith, H ;
Sweet, C .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2389-2400
[9]   Genetic stability of live, cold-adapted influenza virus components of the FluMist®/CAIV-T vaccine throughout the manufacturing process [J].
Buonagurio, DA ;
Bechert, TM ;
Yang, CF ;
Shutyak, L ;
D'Arco, GA ;
Kazachkov, Y ;
Wang, HP ;
Rojas, EA ;
O'Neill, RE ;
Spaete, RR ;
Coelingh, KL ;
Zamb, TJ ;
Sidhu, MS ;
Udem, SA .
VACCINE, 2006, 24 (12) :2151-2160
[10]   NEW technologies for meeting the global demand for pandemic influenza vaccines [J].
Fedson, David S. .
BIOLOGICALS, 2008, 36 (06) :346-349